Gelatinase inhibitors: a patent review (2011-2017)-Reference-Cited by-同舟云学术

Gelatinase inhibitors: a patent review (2011-2017)

Published:2017-11-12 Issue:1 Volume:28 Page:31-46
ISSN:1354-3776
Container-title:Expert Opinion on Therapeutic Patents
language:en
Short-container-title:Expert Opinion on Therapeutic Patents

Author:

Li Xun¹

Affiliation:

1. Department of Medicinal Chemistry, Key laboratory of Chemistry and Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, Ji’nan, PR China

Funder

the Science and Technology Major Projects of Shandong Province

the Rolling program of “ChangJiang Scholars and Innovative Research Team in University”

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543776.2018.1397132

Reference73 articles.

1. Design and Therapeutic Application of Matrix Metalloproteinase Inhibitors

2. New intracellular activities of matrix metalloproteinases shine in the moonlight

3. Anacardic acid inhibits gelatinases through the regulation of Spry2, MMP-14, EMMPRIN and RECK

4. Matrix metalloproteases: Underutilized targets for drug delivery

5. An Updated Patent Therapeutic Agents Targeting MMPs

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Matrix metalloproteases;Metalloenzymes;2024

2. An updated patent review of matrix metalloproteinase (MMP) inhibitors (2021-present);Expert Opinion on Therapeutic Patents;2023-10-03

3. Outline of gelatinase inhibitors as anti-cancer agents: A patent mini-review for 2010-present;European Journal of Medicinal Chemistry;2021-03

4. Novel matrix metalloproteinase inhibitors: an updated patent review (2014 - 2020);Expert Opinion on Therapeutic Patents;2021-02-22

5. The Effect of Immunosuppressive Drugs on MMPs Activity in The Walls of Blood Vessels - A Systematic Review;International Journal of Medical Sciences;2021